Müller L, Kasper P, Madle S
Institute for Drugs, Federal Health Agency, Berlin, F.R.G.
Mutat Res. 1991 Jun;263(2):83-92. doi: 10.1016/0165-7992(91)90064-b.
Paracetamol (PCM) and acetylsalicylic acid (ASA), both widely used analgesics, were tested for their clastogenicity in V79 cells in vitro. Rat liver S9 mix and primary rat hepatocytes (PRH) were used as external activation systems. ASA was found to be negative with and without activation system in concentrations up to 10(-2) M. In contrast PCM induced concentration-dependent chromosomal aberrations with and without activation system within the range of 3 x 10(-3) and 10(-2) M. The greatest effects were observed following continuous treatment with PRH activation and without external metabolization. Pulse treatments without external metabolization, with S9 mix and PRH were less effective. The clastogenic potency of PCM seems to be partly independent of metabolic activation. Although clastogenic effects in vitro were observed only in very high concentrations pharmacokinetic data and other published mutagenicity data indicate that there might be a risk for human use. Peak plasma levels of more than 10(-4) M have been reported (Forrest et al., 1982) and 2 groups of investigators (Kocisova et al., 1988; Hongslo et al., 1990) found PCM to be weakly clastogenic in human lymphocytes in vivo in the maximum human therapeutic dose range.
对乙酰氨基酚(PCM)和乙酰水杨酸(ASA)这两种广泛使用的镇痛药进行了体外V79细胞致断裂性测试。大鼠肝脏S9混合液和原代大鼠肝细胞(PRH)用作体外活化系统。结果发现,在浓度高达10⁻²M时,无论有无活化系统,ASA均呈阴性。相比之下,在3×10⁻³至10⁻²M范围内,无论有无活化系统,PCM均可诱导浓度依赖性染色体畸变。在PRH活化且无体外代谢的连续处理后观察到最大效应。无体外代谢、使用S9混合液和PRH的脉冲处理效果较差。PCM的致断裂效力似乎部分独立于代谢活化。尽管仅在非常高的浓度下观察到体外致断裂效应,但药代动力学数据和其他已发表的致突变性数据表明,PCM在人类使用中可能存在风险。已有报告称血浆峰值水平超过10⁻⁴M(Forrest等人,1982年),两组研究人员(Kocisova等人,1988年;Hongslo等人,1990年)发现,在最大人类治疗剂量范围内,PCM在体内对人类淋巴细胞具有弱致断裂性。